ocrelizumab
CAS No. 637334-45-3
(e)-3-amino-3-phenylprop-2-enethioamide
1057326-92-7
4-Amino-7-trifluoromethoxyquinoline
1065092-25-2
4-Amino-3-bromo-5,8-difluoroquinoline
1065088-54-1
7-fluoro-8-methylquinolin-4(1H)-one
1065092-79-6
Quinoline, 3-[(octacosyloxy)methyl]-
874360-66-4
L-Proline, octacosyl ester
874360-29-9
4-(6-chloropyridin-3-yl)-6,7-dimethoxycinnoline
1057337-34-4
1H-Pyrrolo[2,3-b]pyridine-5,6-dicarbonitrile
1057077-52-7
3-Bromo-4-hydroxy-6-trifluoromethoxyquinoline
1065087-86-6
1-Butene, 1,1,2,3,4,4-hexafluoro-
256334-89-1
3-Piperidinecarboxylic acid, octacosyl ester
874360-61-9
1-methyl-1H-1,2,3-benzotriazole-5-carbonitrile
1065100-55-1
ethyl 4-amino-2-chloro-5-iodobenzoate
1057076-51-3
2-piperidinylmethyl Acetate Hydrochloride (1:1)
264924-32-5
Benzo[b]thiophene, 2-[(octacosyloxy)methyl]-
874360-46-0
Benzenepropanoic acid, 4-(2-propyn-1-yloxy)-
1057664-09-1
Quinoline, 2-[(octacosyloxy)methyl]-
874360-25-5
1-cyclohexyl-3-phenylurea
86759-64-0